Therapeutic Hypothermia Systems Market Size, Share, and Trends 2024 to 2034

The global therapeutic hypothermia systems market size is calculated at USD 318.81million in 2025 and is forecasted to reach around USD 487.42 million by 2034, accelerating at a CAGR of 4.83% from 2025 to 2034. The North America market size surpassed USD 124.69 million in 2024 and is expanding at a CAGR of 4.95% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 5735
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Therapeutic Hypothermia Systems Market 

5.1. COVID-19 Landscape: Therapeutic Hypothermia Systems Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Therapeutic Hypothermia Systems Market, By Product

8.1. Therapeutic Hypothermia Systems Market Revenue and Volume, By Product

8.1.1 Cooling Catheters

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Water Blankets

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Cool Caps

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Cooling Devices

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Therapeutic Hypothermia Systems Market, By Application

9.1. Therapeutic Hypothermia Systems Market Revenue and Volume, By Application

9.1.1. Neurology

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Cardiology

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Neonatal Care

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Therapeutic Hypothermia Systems Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, By Product

10.1.2. Market Revenue and Volume Forecast, By Application

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, By Product

10.1.3.2. Market Revenue and Volume Forecast, By Application

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, By Product

10.1.4.2. Market Revenue and Volume Forecast, By Application

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, By Product

10.2.2. Market Revenue and Volume Forecast, By Application

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, By Product

10.2.3.2. Market Revenue and Volume Forecast, By Application

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, By Product

10.2.4.2. Market Revenue and Volume Forecast, By Application

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, By Product

10.2.5.2. Market Revenue and Volume Forecast, By Application

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, By Product

10.2.6.2. Market Revenue and Volume Forecast, By Application

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, By Product

10.3.2. Market Revenue and Volume Forecast, By Application

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, By Product

10.3.3.2. Market Revenue and Volume Forecast, By Application

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, By Product

10.3.4.2. Market Revenue and Volume Forecast, By Application

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, By Product

10.3.5.2. Market Revenue and Volume Forecast, By Application

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, By Product

10.3.6.2. Market Revenue and Volume Forecast, By Application

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, By Product

10.4.2. Market Revenue and Volume Forecast, By Application

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, By Product

10.4.3.2. Market Revenue and Volume Forecast, By Application

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, By Product

10.4.4.2. Market Revenue and Volume Forecast, By Application

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, By Product

10.4.5.2. Market Revenue and Volume Forecast, By Application

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, By Product

10.4.6.2. Market Revenue and Volume Forecast, By Application

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, By Product

10.5.2. Market Revenue and Volume Forecast, By Application

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, By Product

10.5.3.2. Market Revenue and Volume Forecast, By Application

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, By Product

10.5.4.2. Market Revenue and Volume Forecast, By Application

Chapter 11. Company Profiles

11.1. Asahi Kasei Corporation

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Audax Management Company, LLC.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Belmont Medical Technologies

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. BrainCool AB

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. ZOLL Medical Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Becton, Dickinson, and Company

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Stryker Corporation

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. EM-MED Sp. z o.o.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Life Recovery Systems

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Drägerwerk AG & Co. KgaA

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global therapeutic hypothermia systems market size is expected to grow from USD 304.12 million in 2024 to USD 487.42 million by 2034.

The therapeutic hypothermia systems market is anticipated to grow at a CAGR of 4.83% between 2025 and 2034.

The major players operating in the therapeutic hypothermia systems market are Asahi Kasei Corporation, Audax Management Company, LLC., Belmont Medical Technologies, BrainCool AB, ZOLL Medical Corporation, Becton, Dickinson, and Company, Stryker Corporation, EM-MED Sp. z o.o., Life Recovery Systems, Drägerwerk AG & Co. KgaA, Terumo Cardiovascular Systems Corporation, pfm medical gmbh, and Others.

The driving factors of the therapeutic hypothermia systems market are the rising cases of cardiovascular conditions like cardiac arrest, stroke, and myocardial infections (MI) boost the growth of the market.

North America region will lead the global therapeutic hypothermia systems market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client